{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2023-N-3392\" and posted_year = 2023 sorted by posted_date descending", "rows": [["FDA-2023-N-3392-0019", "FDA", "FDA-2023-N-3392", "Reference 17 - Hutchings M., A. Truman, and B. Wilkinson, \u201cAntibiotics: Past, Present and Future,\u201d Current Opinion in Microbiology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:08:14Z", null, 0, 0, "090000648630c910"], ["FDA-2023-N-3392-0035", "FDA", "FDA-2023-N-3392", "Reference 33 - Leonel C., I. Sena, W. Silva, et al., \u201cStaphylococcus Epidermidis Role in the Skin Microenvironment,\u201d Journal of Cellular And Molecular Medicine", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:13:08Z", null, 0, 0, "090000648630cbac"], ["FDA-2023-N-3392-0005", "FDA", "FDA-2023-N-3392", "Reference 3 - General and Plastic Surgery Devices Panel, \u201c2016 Meeting Materials of the General and Plastic Surgery Advisory Panel--September 20-21, 2016\u201d", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:04:06Z", null, 0, 0, "090000648630c213"], ["FDA-2023-N-3392-0007", "FDA", "FDA-2023-N-3392", "Reference 5 - Sen C., G. Gordillo, S. Roy, et al., \u201cHuman Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy,\u201d Wound Repair and Regeneration", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:04:40Z", null, 0, 0, "090000648630c215"], ["FDA-2023-N-3392-0012", "FDA", "FDA-2023-N-3392", "Reference 10 - Hess C.T., \u201cPutting the Squeeze on Venous Ulcers,\u201d Nursing", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:06:00Z", null, 0, 0, "090000648630c368"], ["FDA-2023-N-3392-0016", "FDA", "FDA-2023-N-3392", "Reference 14 - Gottrup F., J. Apelqvist, T. Bjarnsholt, et al., \u201cAntimicrobials and Non-Healing Wounds: Evidence, Controversies, and Suggestions--Key Messages,\u201d Journal of Wound Care", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:07:06Z", null, 0, 0, "090000648630c439"], ["FDA-2023-N-3392-0020", "FDA", "FDA-2023-N-3392", "Reference 18 - CDC, Antibiotic Resistance Threats in the United States 2019 Report", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:08:26Z", null, 0, 0, "090000648630c913"], ["FDA-2023-N-3392-0031", "FDA", "FDA-2023-N-3392", "Reference 29 - Government of Canada, \u201cCategorization of Antimicrobial Drugs Based on Importance in Human Medicine,\u201d 2009", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:12:01Z", null, 0, 0, "090000648630ca93"], ["FDA-2023-N-3392-0004", "FDA", "FDA-2023-N-3392", "Reference 2 - General and Plastic Surgery Devices Panel, \u201cBrief Summary from the General and Plastic Surgery Devices Panel Meeting--August 25-26, 2005\u201d", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:03:43Z", null, 0, 0, "090000648630bc20"], ["FDA-2023-N-3392-0025", "FDA", "FDA-2023-N-3392", "Reference 23 - Munita J. and C. Arias, \u201cMechanisms of Antibiotic Resistance,\u201d Microbiology Spectrum", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:10:16Z", null, 0, 0, "090000648630c9ee"], ["FDA-2023-N-3392-0039", "FDA", "FDA-2023-N-3392", "Reference 37 - Burke T., M. Rupp, P. Fey, \u201cStaphylococcus Epidermidis,\u201d Trends in Microbiology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:14:23Z", null, 0, 0, "090000648630cbb0"], ["FDA-2023-N-3392-0013", "FDA", "FDA-2023-N-3392", "Reference 11 - Driver V., M. Fabbi, L. Lavery, et al., \u201cThe Costs of Diabetic Foot: The Economic Case for the Limb Salvage Team,\u201d Journal of Vascular Surgery", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:06:18Z", null, 0, 0, "090000648630c36d"], ["FDA-2023-N-3392-0043", "FDA", "FDA-2023-N-3392", "Reference 41 -  Choi Y., K. Campbell, C. Levek, et al., \u201cAntibiotic Ointment Versus a Silver-Based Dressing for Children With Extremity Burns: A Randomized Controlled Study,\u201d Journal of Pediatric Surgery", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:15:30Z", null, 0, 0, "090000648630cc34"], ["FDA-2023-N-3392-0055", "FDA", "FDA-2023-N-3392", "Reference 53 - Luqman A., M. Muttaqin, S. Yulaipi, et al., \u201cTrace Amines Produced by Skin Bacteria Accelerate Wound Healing in Mice,\u201d Communications Biology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:19:29Z", null, 0, 0, "090000648630d2a9"], ["FDA-2023-N-3392-0021", "FDA", "FDA-2023-N-3392", "Reference 19 - Dadgostar P., \u201cAntimicrobial Resistance: Implications and Costs.,\u201d Infection and Drug Resistance", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:09:03Z", null, 0, 0, "090000648630c915"], ["FDA-2023-N-3392-0048", "FDA", "FDA-2023-N-3392", "Reference 46 - Serena T., L. Serena, O. Al-Jalodi, et al., \u201cThe Efficacy of Sodium Hypochlorite Antiseptic: A Double-Blind, Randomised Controlled Pilot Study,\u201d Journal of Wound Care", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:17:11Z", null, 0, 0, "090000648630d115"], ["FDA-2023-N-3392-0049", "FDA", "FDA-2023-N-3392", "Reference 47 - Saad A., E. Salazar, L. Allen, et al., \u201cAntimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery: A Randomized Controlled Trial,\u201d American Journal of Perinatology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:17:20Z", null, 0, 0, "090000648630d116"], ["FDA-2023-N-3392-0051", "FDA", "FDA-2023-N-3392", "Reference 49 - Linehanm J., O. Harrison, S. Han, et al., \u201cNon-Classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair,\u201d Cell", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:17:57Z", null, 0, 0, "090000648630d119"], ["FDA-2023-N-3392-0053", "FDA", "FDA-2023-N-3392", "Reference 51 - Leonel C., I. Sena, W. Silva, et al., \u201cStaphylococcus Epidermidis Role in the Skin Microenvironment,\u201d Journal of Cellular and Molecular Medicine", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:18:33Z", null, 0, 0, "090000648630d2a3"], ["FDA-2023-N-3392-0040", "FDA", "FDA-2023-N-3392", "Reference 38 - FDA, \u201cClassification of Products as Drugs and Devices & Additional Product Classification Issues: Guidance for Industry and FDA Staff,\u201d September 2017", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:14:36Z", null, 0, 0, "090000648630cc31"], ["FDA-2023-N-3392-0015", "FDA", "FDA-2023-N-3392", "Reference 13 - Guo S. and L.A. DiPietro, \u201cFactors Affecting Wound Healing,\u201d Journal of Dental Research", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:06:53Z", null, 0, 0, "090000648630c435"], ["FDA-2023-N-3392-0034", "FDA", "FDA-2023-N-3392", "Reference 32 - Johnson T., B. Gomez, M. McIntyre, et al., \u201cThe Cutaneous Microbiome and Wounds: New Molecular Targets To Promote Wound Healing,\u201d International Journal of Molecular Sciences", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:12:58Z", null, 0, 0, "090000648630ca9b"], ["FDA-2023-N-3392-0041", "FDA", "FDA-2023-N-3392", "Reference 39 - FDA, \u201cGeneral and Plastic Surgery Devices; Classification of the Nonresorbable Gauze/Sponge for External Use, the Hydrophilic Wound Dressing, the Occlusive Wound Dressing, and the Hydrogel Wound Dressing,\u201d 64 FR 53927, October 5, 1999", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:15:05Z", null, 0, 0, "090000648630cc32"], ["FDA-2023-N-3392-0003", "FDA", "FDA-2023-N-3392", "Reference 1 - General and Plastic Surgery Devices Panel, \u201cTranscript of the FDA General and Plastic Surgery Devices Panel meeting - November 17, 1998\"", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:03:11Z", null, 0, 0, "090000648630bc1f"], ["FDA-2023-N-3392-0002", "FDA", "FDA-2023-N-3392", "List of References", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:02:58Z", null, 0, 0, "090000648630bc1c"], ["FDA-2023-N-3392-0006", "FDA", "FDA-2023-N-3392", "Reference 4 - WHO, \u201cCritically Important Antimicrobials For Human Medicine: 6th Revision\u201d", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:04:24Z", null, 0, 0, "090000648630c214"], ["FDA-2023-N-3392-0008", "FDA", "FDA-2023-N-3392", "Reference 6 - Nussbaum S., M. Carter, C. Fife, et al., \u201cAn Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds,\u201d Value in Health", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:05:02Z", null, 0, 0, "090000648630c217"], ["FDA-2023-N-3392-0037", "FDA", "FDA-2023-N-3392", "Reference 35 - Luqman A., M. Muttaqin, S. Yulaipi, et al., \u201cTrace Amines Produced by Skin Bacteria Accelerate Wound Healing in Mice,\u201d Communications Biology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:13:47Z", null, 0, 0, "090000648630cbae"], ["FDA-2023-N-3392-0038", "FDA", "FDA-2023-N-3392", "Reference 36- Brown M., A. Horswill, \u201cStaphylococcus Epidermidis--Skin Friend or Foe?\u201d PLOS Pathogens", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:14:13Z", null, 0, 0, "090000648630cbaf"], ["FDA-2023-N-3392-0028", "FDA", "FDA-2023-N-3392", "Reference 26 - Peleg A., and D. Hooper. \u201cHospital-Acquired Infections Due to Gram-Negative Bacteria,\u201d The New England Journal of Medicine", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:11:13Z", null, 0, 0, "090000648630c9f5"], ["FDA-2023-N-3392-0030", "FDA", "FDA-2023-N-3392", "Reference 28 - FDA, \u201cEvaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern: Guidance for Industry,\u201d October 23, 2003", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:11:37Z", null, 0, 0, "090000648630ca92"], ["FDA-2023-N-3392-0032", "FDA", "FDA-2023-N-3392", "Reference 30 - McDonnell G., and A. Russell, \u201cAntiseptic and Disinfectants: Activity, Action, and Resistance,\u201d Clinical Microbiology Reviews", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:12:10Z", null, 0, 0, "090000648630ca95"], ["FDA-2023-N-3392-0042", "FDA", "FDA-2023-N-3392", "Reference 40 - FDA, \u201cMedical Devices; Plastic Surgery Devices; Classification of Wound Dressing With Poly (Diallyl Dimethyl Ammonium Chloride) Additive,\u201d 74 FR 53165, October 16, 2009", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:15:20Z", null, 0, 0, "090000648630cc33"], ["FDA-2023-N-3392-0045", "FDA", "FDA-2023-N-3392", "Reference 43 - Kim D., W. Namen Ii, J. Moore, et al., \u201cClinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach,\u201d Wounds", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:16:12Z", null, 0, 0, "090000648630cc36"], ["FDA-2023-N-3392-0057", "FDA", "FDA-2023-N-3392", "Reference 55 - Burke T., M. Rupp, P. Fey, \u201cStaphylococcus Epidermidis,\u201d Trends in Microbiology, 2023", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:19:47Z", null, 0, 0, "090000648630d2c4"], ["FDA-2023-N-3392-0058", "FDA", "FDA-2023-N-3392", "Reference 56 - FDA\u2019s Full Preliminary Analysis of Economic Impacts", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:20:10Z", null, 0, 0, "090000648630d2c5"], ["FDA-2023-N-3392-0014", "FDA", "FDA-2023-N-3392", "Reference 12 - Gordon M., M. Gottschlich, E. Helvig, et al., \u201cReview of Evidence-Based Practice for the Prevention of Pressure Sores in Burn Patients,\u201d Journal of Burn Care & Research", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:06:41Z", null, 0, 0, "090000648630c434"], ["FDA-2023-N-3392-0022", "FDA", "FDA-2023-N-3392", "Reference 20 - National Quality Forum, \u201cNQF, CDC Issue Guidance To Help Hospitals Better Manage Use of Antibiotics,\u201d 2016", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:09:13Z", null, 0, 0, "090000648630c916"], ["FDA-2023-N-3392-0024", "FDA", "FDA-2023-N-3392", "Reference 22 - HHS, \u201cAntimicrobial Resistance\u201d", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:10:03Z", null, 0, 0, "090000648630c9ed"], ["FDA-2023-N-3392-0029", "FDA", "FDA-2023-N-3392", "Reference 27 - WHO, \u201cBurns\u201d", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:11:24Z", null, 0, 0, "090000648630c9f6"], ["FDA-2023-N-3392-0011", "FDA", "FDA-2023-N-3392", "Reference 9 - Kuhn A., S.J. Coulter, \u201cBalancing Ulcer Cost and Quality Equation,\u201d Nursing Economics", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:05:50Z", null, 0, 0, "090000648630c21a"], ["FDA-2023-N-3392-0023", "FDA", "FDA-2023-N-3392", "Reference 21 - CDC, The Core Elements of Hospital Antibiotic Stewardship Programs: 2019", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:09:32Z", null, 0, 0, "090000648630c919"], ["FDA-2023-N-3392-0036", "FDA", "FDA-2023-N-3392", "Reference 34 - Pastar I., K. O\u2019Neill, L. Padula, et al., \u201cStaphylococcus Epidermidis Boosts Innate Immune Response by Activation of Gamma Delta T Cells and Induction of Perforin-2 in Human Skin,\u201d Frontiers in Immunology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:13:37Z", null, 0, 0, "090000648630cbad"], ["FDA-2023-N-3392-0010", "FDA", "FDA-2023-N-3392", "Reference 8 - Carter M., C. Fife, D. Walker, et al., \u201cEstimating the Applicability of Wound Care Randomized Controlled Trials to General Wound-Care Populations by Estimating the Percentage of Individuals Excluded from a Typical Wound-Care Population in Such Trials,\u201d Advances in Skin & Wound Care", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:05:26Z", null, 0, 0, "090000648630c219"], ["FDA-2023-N-3392-0046", "FDA", "FDA-2023-N-3392", "Reference 44 - Connery S., J. Yankowitz, L. Odibo, et al., \u201cEffect of Using Silver Nylon Dressings To Prevent Superficial Surgical Site Infection After Cesarean Delivery: A Randomized Clinical Trial,\u201d American Journal of Obstetrics and Gynecology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:16:21Z", null, 0, 0, "090000648630cc37"], ["FDA-2023-N-3392-0050", "FDA", "FDA-2023-N-3392", "Reference 48 - Dissemond J., J. Steinmann, K. M\u00fcnter, et al., \u201cRisk and Clinical Impact of Bacterial Resistance/Susceptibility to Silver-Based Wound Dressings: A Systematic Review,\u201d Journal of Wound Care", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:17:30Z", null, 0, 0, "090000648630d117"], ["FDA-2023-N-3392-0052", "FDA", "FDA-2023-N-3392", "Reference 50 - Johnson T., B. Gomez, M. McIntyre, et al., \u201cThe Cutaneous Microbiome and Wounds: New Molecular Targets To Promote Wound Healing,\u201d International Journal of Molecular Science", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:18:23Z", null, 0, 0, "090000648630d11a"], ["FDA-2023-N-3392-0026", "FDA", "FDA-2023-N-3392", "Reference 24 - Bennett, P.M., \u201cPlasmid Encoded Antibiotic Resistance: Acquisition and Transfer of Antibiotic Resistance Genes in Bacteria,\u201d British Journal of Pharmacology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:10:27Z", null, 0, 0, "090000648630c9ef"], ["FDA-2023-N-3392-0044", "FDA", "FDA-2023-N-3392", "Reference 42 - Benedetto A., J. Staidle, J. Schoenfeld, et al., \u201cComparing the Use of a Novel Antibiotic-Free Film-Forming Topical Wound Dressing Versus a Topical Triple Antibiotic in Dermatologic Surgical Procedures Including Mohs Micrographic Surgery,\u201d Journal of European Academy of Dermatology and Venereology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:16:02Z", null, 0, 0, "090000648630cc35"], ["FDA-2023-N-3392-0056", "FDA", "FDA-2023-N-3392", "Reference 54 - Brown M., A. Horswill, \u201cStaphylococcus Epidermidis--Skin Friend or Foe?\u201d PLOS Pathogens", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:19:37Z", null, 0, 0, "090000648630d2aa"], ["FDA-2023-N-3392-0017", "FDA", "FDA-2023-N-3392", "Reference 15 - Sen, C., \u201cHuman Wounds and Its Burden: An Updated Compendium of Estimates,\u201d Advances in Wound Care", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:07:26Z", null, 0, 0, "090000648630c43a"], ["FDA-2023-N-3392-0027", "FDA", "FDA-2023-N-3392", "Reference 25 - Chandan P., J. Bengtsson-Palme, E. Kristiansson, et al., \u201cCo-Occurrence of Resistance Genes to Antibiotics, Biocides and Metals Reveals Novel Insights into Their Co-Selection Potential,\u201d BMC Genomics", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:10:36Z", null, 0, 0, "090000648630c9f2"], ["FDA-2023-N-3392-0018", "FDA", "FDA-2023-N-3392", "Reference 16 - FDA, \u201cSupporting Antimicrobial Stewardship in Veterinary Settings: Goals for Fiscal Years 2024-2028: Key Phase 3 and Key Phase 4 Actions,\u201d September 2023", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:07:37Z", null, 0, 0, "090000648630c43b"], ["FDA-2023-N-3392-0047", "FDA", "FDA-2023-N-3392", "Reference 45 - Ahmad H., K. Kallies, and S. Shapiro, \u201cThe Effect of Mupirocin Dressings on Postoperative Surgical Site Infections in Elective Colorectal Surgery: A Prospective, Randomized Controlled Trial,\u201d The American Journal of Surgery", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:16:31Z", null, 0, 0, "090000648630d114"], ["FDA-2023-N-3392-0054", "FDA", "FDA-2023-N-3392", "Reference 52 - Pastar I., K. O\u2019Neill, L. Padula, et al., \u201cStaphylococcus Epidermidis Boosts Innate Immune Response by Activation of Gamma Delta T Cells and Induction of Perforin-2 in Human Skin,\u201d Frontiers in Immunology", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:18:42Z", null, 0, 0, "090000648630d2a7"], ["FDA-2023-N-3392-0009", "FDA", "FDA-2023-N-3392", "Reference 7 - Berry C., D.R. Murdoch, and J.J. McMurray, \u201cEconomics of Chronic Heart Failure,\u201d European Journal of Heart Failure", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:05:14Z", null, 0, 0, "090000648630c218"], ["FDA-2023-N-3392-0033", "FDA", "FDA-2023-N-3392", "Reference 31 - Linehanm J., O. Harrison, S. Han, et al., \u201cNon-Classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair,\u201d Cell", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:12:22Z", null, 0, 0, "090000648630ca98"], ["FDA-2023-N-3392-0001", "FDA", "FDA-2023-N-3392", "Medical Devices; General and Plastic Surgery Devices; Classification of Certain Solid Wound Dressings;\nWound Dressings Formulated as a Gel, Creams, or Ointment; and Liquid Wound Washes", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2023-11-30T05:00:00Z", 2023, 11, "2023-11-30T05:00:00Z", "2024-02-29T04:59:59Z", "2024-03-19T01:03:58Z", "2023-26209", 0, 0, "09000064862c31a9"]], "truncated": false, "filtered_table_rows_count": 58, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2023-N-3392", "p2": "2023"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023", "results": [{"value": "FDA", "label": "FDA", "count": 58, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2023-N-3392&posted_year=2023", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 57, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023", "results": [{"value": 2023, "label": 2023, "count": 58, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2023-N-3392&posted_year=2023&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1134.8131470149383, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}